Cocrystal Pharma (COCP) Cash from Investing Activities Growth (1y) (2011 - 2024)
Cocrystal Pharma (COCP) Cash from Investing Activities Growth (1y) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 82.22% |
| Dec 31, 2023 | -391.67% |
| Dec 31, 2022 | -50.00% |
| Dec 31, 2021 | -700.00% |
| Sep 30, 2021 | 78.95% |
| Jun 30, 2021 | 88.19% |
| Mar 31, 2021 | 73.12% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 83.48% |
| Jun 30, 2020 | -3,075.00% |
| Mar 31, 2020 | -272.00% |
| Dec 31, 2019 | 93.33% |
| Sep 30, 2019 | -1,337.50% |
| Mar 31, 2019 | -101.79% |
| Dec 31, 2018 | -225.00% |
| Mar 31, 2018 | 4,327.27% |
| Dec 31, 2017 | -65.71% |
| Jun 30, 2017 | 64.81% |
| Mar 31, 2017 | -3,400.00% |
| Dec 31, 2016 | 135.00% |